Organogenesis Reports Fiscal Q2 2026 Results

What Happened

• Organogenesis Holdings, Inc. (ORGO) announced its financial results for the fiscal second quarter ended June 30, 2026 via a press release dated August 6, 2026. The company furnished that press release to the SEC on Form 8‑K (Item 2.02).

Key Details

• Announcement date: August 6, 2026.
• Reporting period: fiscal quarter ended June 30, 2026.
• The press release is furnished as Exhibit 99.1 to the Form 8‑K.
• The company states the press release information is furnished (not “filed”) and therefore not subject to Section 18 liability or automatically incorporated by reference into other filings.

Why It Matters

• This 8‑K provides investors with Organogenesis’s latest quarterly results and financial condition for Q2 2026. Investors should review the furnished press release (Exhibit 99.1) for concrete metrics—such as revenue, earnings, cash flow and any guidance—that could affect the company’s near‑term outlook and stock valuation. Because the release is furnished rather than filed, its legal status is limited under the Exchange Act.